Project Grant R01MD020754
- This $566,573 Project Grant awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a randomized controlled trial to evaluate the impact of point-of-care screening and treatment for Chlamydia trachomatis (CT) infection to prevent preterm birth among asymptomatic pregnant women in Botswana. The study will also assess differential impacts among subgroups...
- The U.S. Department of Health and Human Services, through the Trans-NIH Research Support program (CFDA 93.310), awarded a $267,000 Project Grant to the Icahn School of Medicine at Mount Sinai. This award, effective from June 9, 2025 to June 8, 2027, will fund a pragmatic pilot feasibility trial to test the hypothesis that point-of-care testing for gonorrhea and chlamydia can improve HIV testing, pre-exposure prophylaxis (PrEP) counseling, and PrEP delivery among adolescents seeking sexually...
- The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $306,003 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to ISA Associates, Inc. on September 17, 2025. The award will fund the development and evaluation of a mobile intervention to reduce the impact of chronic stress on preterm birth risk among African American women. ISA Associates, Inc., a for-profit organization with extensive experience in developing and...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $985,308 to the University of Washington to advance the delivery of primary STI and HIV prevention services for cisgender adolescent girls and young women (AGYW) through pharmacy-based interventions. The project aims to investigate strategies to increase STI testing, expedited...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
- This federal Project Grant award of $321,341 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is for the "Maternal Health Navigator Intervention to Reduce Disparities in Severe Maternal Morbidity and Mortality." The grant will fund the design and prototyping of a community-centric intervention called "Pathways Through Pregnancy (PTP)" that...
- This federal Project Grant award of $477,000.00, provided by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307), supports the development of an interactive outbreak simulator platform. The objectives are to create a robust and customizable tool for modeling disease transmission and evaluating the effects of various intervention strategies, with a focus on understanding disease spread within...
- This $797,734 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 9, 2025. The funding supports research by Emory University to investigate the potential anti-inflammatory and microbiome effects of using the antibiotic doxycycline as post-exposure prophylaxis (Doxy-PEP) for sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis among men who have sex...
- This federal Project Grant award of $167,353.00 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research on syphilis in pregnancy. The key objectives are to: Define placental histopathologic phenotypes and correlate them with treponemal burden and neonatal outcomes along a spectrum of clinical syphilis disease, compared to healthy controls. Link differential placental gene...
- The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $165,012 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to the University of North Carolina at Chapel Hill (UNC-CH) to develop and test a multi-level, community-engaged intervention. The intervention aims to increase access to cervical cancer screening using human papillomavirus (HPV) self-collection (HPVSC) outreach and improve navigation for follow-up screening...
The Project Grant award titled "REDUCING MATERNAL AND CHILD HEALTH DISPARITIES THROUGH POINT-OF-CARE STI TESTING IN UNDERSERVED POPULATIONS (MATCH-POINT)" is funded by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307). The $1,318,470.00 grant, awarded to Emory University on September 19, 2025, aims to evaluate the impact of point-of-care testing for sexually transmitted infections (STIs) on treatment time among pregnant women in underserved populations. The study will also assess the implementation processes, costs, and cost-effectiveness of these point-of-care tests for syphilis, gonorrhea, chlamydia, and trichomoniasis. This will be the first study to evaluate the impact and implementation of point-of-care STI testing among pregnant women in the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 9/19/25 |